Dimensional Fund Advisors
IPSC icon

Dimensional Fund Advisors’s Century Therapeutics IPSC Stock Holding History

Dimensional Fund Advisors’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$665K Buy
271,492
+216,309
+392% +$494K ﹤0.01% 2935
2026
Q1 		$122K Buy
+55,183
New +$116K ﹤0.01% 3102
2025
Q2 		– Sell
-26,735
Closed -$12.8K – 3299
2025
Q1 		$12.8K Sell
26,735
-139
-0.5% -$104 ﹤0.01% 3313
2024
Q4 		$27.1K Sell
26,874
-6,575
-20% -$8.95K ﹤0.01% 3322
2024
Q3 		$56.9K Sell
33,449
-41,866
-56% -$82K ﹤0.01% 3288
2024
Q2 		$192K Buy
75,315
+44,155
+142% +$140K ﹤0.01% 3172
2024
Q1 		$130K Sell
31,160
-1,438
-4% -$6.09K ﹤0.01% 3234
2023
Q4 		$108K Buy
32,598
+4,572
+16% +$8.33K ﹤0.01% 3272
2023
Q3 		$56.1K Sell
28,026
-2,465
-8% -$6.56K ﹤0.01% 3369
2023
Q2 		$96.4K Sell
30,491
-8,962
-23% -$28.9K ﹤0.01% 3328
2023
Q1 		$137K Buy
+39,453
New +$173K ﹤0.01% 3265
2022
Q3 		$370K Buy
+37,440
New +$394K ﹤0.01% 3107

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Dimensional Fund Advisors's IPSC Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Century Therapeutics (IPSC) stake by 392% in Q2 2026, buying an estimated $494K and bringing the position to 271,492 shares worth $665K. The position accounts for ﹤0.01% of the portfolio, ranked #2935.

Dimensional Fund Advisors first reported a position in IPSC in Q3 2022 and has held it in 12 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Dimensional Fund Advisors held 271,492 shares of Century Therapeutics worth $665K as of Q2 2026.
  • Dimensional Fund Advisors bought 216,309 Century Therapeutics shares in Q2 2026, an estimated $494K.
  • Century Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2935 holding.
  • Dimensional Fund Advisors first reported a position in Century Therapeutics in Q3 2022 and has held it in 12 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.